[ad_1]
Anvisa (National Health Surveillance Agency) felt that the link between prolonged use of hydrochlorothiazide-containing drugs and the increased risk of non-melanoma skin cancer was plausible.
Anvisa will also request the inclusion of this new information in the leaflet
Hydrochlorothiazide is used in the manufacture of drugs for high blood pressure and the treatment of edema
. Anvisa recommends not to interrupt treatment until after consulting the doctor. Healthcare professionals should inform patients who are already taking hydrochlorothiazide-based medications about the risk of skin cancer other than melanoma.
Anyone who uses drugs containing this substance should regularly check the skin and inform the doctor if they notice any new signs.
Anvisa will also request the inclusion of this new information in the package leaflet of all drugs containing the active ingredient hydrochlorothiazide
Cases of non-melanoma skin cancer are common and occur more frequently in people with skin. Anvisa launches new rare and aggressive cancer drug
[ad_2]
Source link
